Centesis Catheters Market Size
The centesis catheters market, valued at USD 557.08 million in 2025, is expected to reach USD 928.89 million by 2033, growing at a CAGR of 6.60% during the forecast period 2026–2033.
A centesis catheter is a needle catheter used for aspirating and draining small abscesses during procedures such as paracentesis, thoracentesis, arthrocentesis, and amniocentesis.
Centesis catheters market Scope
| Metrics | Details |
| Market CAGR | 6.60% |
| Segments Covered | By Type, By Procedure, By End-User, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
For more insights - Download the Sample
Centesis Catheters Market Trends and Dynamics
The factors influencing the global centesis catheters market are the increasing demand for centesis catheters for target diseases.
The increasing demand for centesis catheters for target diseases is expected to drive market growth in the forecast period
The advantages associated with centesis catheters are expected to increase their demand in the market. Because the catheter's low profile, tapered tip, and smooth transitions reduce resistance, resulting in less patient discomfort. Its echo-enhanced needle enables more precise placement. For maximum drainage, four large drainage holes spiral around the catheter. Up to 34% LESS catheter tip penetration force and up to 16% FASTER flow rate Insertion is safe and controlled, with shorter procedure times. For instance, the valved One-Step centesis catheter incorporates a self-sealing valve to reduce the risk of air entering the pleural space.
Moreover, Becton, Dickinson, and Company’s Safe-T-Centesis thoracentesis/paracentesis device help to reduce the risks associated with percutaneous needle drainage. The latex-free device can also help improve patient comfort and procedural flexibility during thoracentesis and paracentesis procedures. Hence, many companies manufacture centesis catheters with several benefits that are expected to drive market growth.
The problems associated with centesis catheters are expected to hamper the market growth
The complexities associated with centesis procedures are one of the factors expected to hamper the market. For instance, thoracentesis is a common procedure performed in inpatient and outpatient settings by many healthcare providers. Although thoracentesis is generally regarded as a low-risk procedure, complications include pneumothorax, bleeding (puncture site bleeding, chest wall hematoma, and hemothorax), and re-expansion pulmonary edema (REPE) can result in increased morbidity, mortality, and healthcare costs. Although ultrasound and an emphasis on operator expertise have significantly reduced complication rates, pneumothorax remains the most common complication of thoracentesis. REPE is another uncommon complication of thoracentesis. Avoiding excessively negative pleural pressures, either through direct measurement or by paying attention to patient symptoms, may lower the risk of REPE.
Centesis Catheters Market Segment and Shares
Based on procedure Paracentesis segment is expected to dominate the global centesis catheters market
Paracentesis is a procedure that involves inserting a needle or catheter into the peritoneal cavity to collect ascitic fluid for diagnostic or therapeutic purposes. Ascitic fluid can be used to help determine the cause of ascites, as well as to check for infection or the presence of cancer. Paracentesis is a procedure used to obtain a small ascitic fluid sample or drain it for diagnostic or therapeutic purposes. A needle or catheter is inserted into the peritoneal cavity for diagnostic or therapeutic purposes, and ascitic fluid is removed. The needle is inserted at a 45-degree angle or using a z-tracking technique to reduce the risk of developing an ascites fluid leak. There are prepackaged paracentesis kits available, including plastic sheath cannulas attached to a syringe and a stopcock. Traditional large-bore intravenous (IV) catheters and 18-gauge to 20-gauge standard or spinal needles can also be used. These can be connected to a syringe for aspiration and IV tubing for fluid drainage. Hence, with the increase in paracentesis procedures, the demand for centesis catheters is also expected to grow.
Centesis Catheters Market Geographical Analysis
North America region is expected to hold the largest market share in the global centesis catheters market
This region is expected to dominate the market due to the high volume of cardiovascular, neurovascular, and other target procedures. The presence of a well-established healthcare system and increasing investments by hospitals to upgrade their medical supplies are driving the growth of this regional market. For instance, with over 200,000 procedures performed each year in the United States, bypass surgery is the most common type of heart surgery.
The presence of major key players is expected to drive market growth in this region. For instance, Merit Medical Systems, Inc. in the United States is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company’s One-Step centesis catheter has a low profile, tapered tip, and smooth transitions to reduce resistance and discomfort in the patient. Its echo-enhanced needle allows for more precise placement, and the four large drainage holes spiral around the catheter to provide maximum drainage.
Centesis Catheters Companies and Competitive Landscape
With mergers, acquisitions, and product launches, the global centesis catheters market is moderately competitive. Some of the key players in the market are Argon Medical, AngioDynamics, Becton, Dickinson and Company, Blue Neem Medical Devices, Boston Scientific Corporation, Cardinal Health, KM Medical, Mermaid Medical A/S, Cook Medical, Galt Medical Corp.
Galt Medical Corp
Overview: Galt Medical Corp. is a leading provider of vascular and interventional medical devices, developing and manufacturing various products for interventional procedures. Through a network of distributors, they provide privately labeled products to medical device OEMs, and Galt-branded products to clinicians worldwide. Clinicians use Galt products on six continents for a variety of Interventional Radiology, Interventional Cardiology Vascular Surgery, and IV Therapy procedures. The company was founded in 1991.
Product Portfolio: The Galt Medical Corp. OTN system is designed to improve ease in every centesis procedure, with three large, skived holes, a smooth transition, and a secure slip-fit needle design.
Recent Developments:
- January 2026: Becton, Dickinson and Company (BD) expanded its drainage and centesis catheter portfolio by integrating advanced needle guidance technology into its ultrasound-compatible catheter kits, improving procedural accuracy in paracentesis and thoracentesis procedures, as confirmed via product updates on its interventional segment.
- November 2025: Teleflex Incorporated announced enhancements to its Arrow® centesis catheter systems, focusing on improved safety valves and fluid control mechanisms to reduce infection risks and procedural complications, as highlighted in its vascular access product portfolio updates.
- December 2025: B. Braun Melsungen AG expanded its presence in Asia-Pacific by promoting advanced centesis and drainage catheter kits across key markets including India and Southeast Asia, focusing on infection prevention and sterile, single-use systems for hospital settings.
- October 2025: Terumo Corporation (Japan) strengthened its interventional product line by optimizing catheter-based drainage solutions, with a focus on precision manufacturing and compatibility with imaging-guided procedures in Japanese healthcare facilities.
